11/09/2020 8:35 PM
Clarín.com
Society
Updated 11/09/2020 8:35 PM
The Ministry of Health reported this Monday that 349 deaths from coronavirus were reported and that 8,317 new infections were identified in the last 24 hours.
The data is known while the tests and investigations of the world-wide laboratories advance to obtain a vaccine against the disease.
This Monday it became known that the US pharmaceutical Pfizer claimed that its vaccine is "90% effective", according to the first interim analysis of its phase 3 trial, the last stage before formally requesting its approval.
This protective efficacy against the SARS-CoV-2 virus was achieved
seven days after the second dose of vaccine and 28 days after the first
, the US pharmaceutical company indicated in a joint statement with BioNTech.
The data is more than optimistic since the scientists expected an effectiveness of around 75%.
Argentina is one of the countries in which the Pfizer vaccine tests are carried out
.
About 4,500 volunteers received the two doses and it was "very well tolerated by all participants."
All vaccines have the same objective: to
train the immune system
to recognize the coronavirus and thus raise its defenses in a preventive way,
in order to neutralize the real virus if contagion occurs.
Since the pandemic began, more than 50 million cases have been diagnosed globally and
more than 1.2 million deaths have been recorded.
Look also
Keys to Pfizer's Vaccine Candidate Announcement
Pfizer vaccine against coronavirus: what happened to the Argentines who already tried it